- Home
- PEN vs SF Comparison
PEN vs SF Comparison
Compare PEN & SF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- SF
- Stock Information
- Founded
- PEN 2004
- SF 1890
- Country
- PEN United States
- SF United States
- Employees
- PEN N/A
- SF N/A
- Industry
- PEN Medical/Dental Instruments
- SF Investment Bankers/Brokers/Service
- Sector
- PEN Health Care
- SF Finance
- Exchange
- PEN Nasdaq
- SF Nasdaq
- Market Cap
- PEN 10.5B
- SF 8.5B
- IPO Year
- PEN 2015
- SF N/A
- Fundamental
- Price
- PEN $277.35
- SF $85.13
- Analyst Decision
- PEN Strong Buy
- SF Hold
- Analyst Count
- PEN 16
- SF 8
- Target Price
- PEN $290.93
- SF $105.71
- AVG Volume (30 Days)
- PEN 451.5K
- SF 1.1M
- Earning Date
- PEN 04-23-2025
- SF 04-23-2025
- Dividend Yield
- PEN N/A
- SF 2.16%
- EPS Growth
- PEN N/A
- SF 46.03
- EPS
- PEN 0.36
- SF 6.25
- Revenue
- PEN $1,194,615,000.00
- SF $4,944,918,000.00
- Revenue This Year
- PEN $14.26
- SF $12.84
- Revenue Next Year
- PEN $14.21
- SF $9.95
- P/E Ratio
- PEN $762.38
- SF $13.62
- Revenue Growth
- PEN 12.86
- SF 14.36
- 52 Week Low
- PEN $148.00
- SF $73.27
- 52 Week High
- PEN $310.00
- SF $120.64
- Technical
- Relative Strength Index (RSI)
- PEN 53.70
- SF 43.24
- Support Level
- PEN $253.27
- SF $82.79
- Resistance Level
- PEN $278.39
- SF $86.63
- Average True Range (ATR)
- PEN 14.09
- SF 4.95
- MACD
- PEN 0.97
- SF 0.26
- Stochastic Oscillator
- PEN 90.04
- SF 50.19
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About SF Stifel Financial Corporation
Stifel Financial is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 67% of the company's net revenue is derived from its global wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial-services firms.